C. Cancès

Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study

A. Chabanon, A. Seferian, Aurore Daron et al. · PLoS ONE · 2018 · 146 citations · Full text

Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype

Laurent Servais, Marie Montus, Caroline Le Guiner et al. · Journal of Neuromuscular Diseases · 2015 · 33 citations · Full text

Etiology of neonatal seizures and maintenance therapy use: a 10-year retrospective study at Toulouse Children’s hospital

Éloïse Baudou, C. Cancès, Chloé Dimeglio et al. · BMC Pediatrics · 2019 · 16 citations · Full text

Implementation of Motor Function Measure score percentile curves - Predicting motor function loss in Duchenne muscular dystrophy

Patricia Hafner, Simone Schmidt, Sabine Schädelin et al. · European Journal of Paediatric Neurology · 2021 · 15 citations · Full text

Physical Activity, Kinesiology, Duchenne Muscular Dystrophy +11

Real-world multidisciplinary outcomes of onasemnogene abeparvovec monotherapy in patients with spinal muscular atrophy type 1: experience of the French cohort in the first three years of treatment

Isabelle Desguerre, Rémi Barrois, Frédérique Audic et al. · Orphanet Journal of Rare Diseases · 2024 · 13 citations · Full text